Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Insulin Resistance × Octreotide × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 6 Neoplasms 4 Carcinoid Tumor 4 Carcinoma 3 Vipoma 2 Neoplasm Metastasis 2 Intestinal Obstruction 2 Carcinoma, Islet Cell 2 Somatostatinoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Inoperable Thymoma 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Malignant Carcinoid Syndrome 1 Lymphangiomyoma 1 Lymphangioleiomyomatosis 1 Insulinoma 1 Glucagonoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Gastrinoma 1 Diarrhea 1 Chylous Ascites 1 Chylothorax 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1 Ascites 1 Adenoma, Islet Cell 1

Interventions

Metformin 5 Pioglitazone 2 ziprasidone 1 salicylsalicylic acid 1 licogliflozin 1 drospirenone and ethinyl estradiol combination 1 drospirenone 1 cinnulin PF 1 Vitamin D 1 Sugars 1 Sodium Salicylate 1 Resistance Training 1 Olanzapine 1 Leuprolide 1 Flutamide 1 Exercise 1 Ethinyl Estradiol 1 Estrogens 1 Diet Therapy 1 Continuous Positive Airway Pressure 1 Cholecalciferol 1 Caloric Restriction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡